Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583-591.

Joentausta RM, Murtola TJ.

Prostate. 2019 Sep;79(12):1420-1421. doi: 10.1002/pros.23870. Epub 2019 Jun 24. No abstract available.

PMID:
31233216
2.

Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.

Joentausta RM, Rannikko A, Murtola TJ.

Prostate. 2019 May;79(6):583-591. doi: 10.1002/pros.23768. Epub 2019 Jan 16.

PMID:
30652328
3.

RE: Joentausta et al. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583-591.

Kawada T.

Prostate. 2019 Sep;79(12):1399. doi: 10.1002/pros.23862. Epub 2019 Jul 23. No abstract available.

PMID:
31334855
4.

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

Murtola TJ, Tammela TL, Määttänen L, Huhtala H, Platz EA, Ala-Opas M, Stenman UH, Auvinen A.

Int J Cancer. 2010 Oct 1;127(7):1650-9. doi: 10.1002/ijc.25165.

5.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.

PMID:
28753762
6.

Statin use and risk of disease recurrence and death after radical prostatectomy.

Keskiväli T, Kujala P, Visakorpi T, Tammela TL, Murtola TJ.

Prostate. 2016 Apr;76(5):469-78. doi: 10.1002/pros.23138. Epub 2015 Dec 22.

PMID:
26689439
7.

Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy.

Bañez LL, Klink JC, Jayachandran J, Lark AL, Gerber L, Hamilton RJ, Masko EM, Vollmer RT, Freedland SJ.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):722-8. doi: 10.1158/1055-9965.EPI-09-1074. Epub 2010 Feb 16.

8.

Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.

Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.

BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.

9.

Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy.

Rantaniemi L, Tammela TLJ, Kujala P, Murtola TJ.

Scand J Urol. 2018 Aug;52(4):269-276. doi: 10.1080/21681805.2018.1492967. Epub 2018 Oct 26.

PMID:
30362865
10.

Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis.

Mass AY, Agalliu I, Laze J, Lepor H.

J Urol. 2012 Sep;188(3):786-91. doi: 10.1016/j.juro.2012.05.011. Epub 2012 Jul 19.

PMID:
22818136
11.

Is statin use associated with prostate cancer aggressiveness?

Loeb S, Kan D, Helfand BT, Nadler RB, Catalona WJ.

BJU Int. 2010 May;105(9):1222-5. doi: 10.1111/j.1464-410X.2009.09007.x. Epub 2009 Nov 3.

12.

Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ.

BJU Int. 2014 Nov;114(5):661-6. doi: 10.1111/bju.12720. Epub 2014 May 8.

13.

Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study.

Cattarino S, Seisen T, Drouin SJ, Renard-Penna R, Leon P, Comperat E, Mozer P, Cussenot O, Rouprêt M.

Can J Urol. 2015 Apr;22(2):7703-8.

PMID:
25891333
14.

Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen.

Krane LS, Kaul SA, Stricker HJ, Peabody JO, Menon M, Agarwal PK.

J Urol. 2010 Jan;183(1):118-24. doi: 10.1016/j.juro.2009.08.151.

PMID:
19913252
15.

Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.

Hamilton RJ, Banez LL, Aronson WJ, Terris MK, Platz EA, Kane CJ, Presti JC Jr, Amling CL, Freedland SJ.

Cancer. 2010 Jul 15;116(14):3389-98. doi: 10.1002/cncr.25308.

16.

Preoperative Statin Use Associated With Lower PSA But Similar Prostate Size and Histopathologic Outcomes: Implications for Active Surveillance?

Stensland K, McBride RB, Leapman M, Hobbs A, Jazayeri SB, Samadi DB.

Urol J. 2017 May 23;14(3):3064-3070.

17.

Statin use, high cholesterol and prostate cancer progression; results from HCaP-NC.

Allott EH, Farnan L, Steck SE, Song L, Arab L, Su LJ, Fontham ETH, Mohler JL, Bensen JT.

Prostate. 2018 Aug;78(11):857-864. doi: 10.1002/pros.23644. Epub 2018 May 1.

PMID:
29717502
18.

Impact of HMG-CoA reductase inhibitor (statin) use on blood loss during robot-assisted and open radical prostatectomy.

Truesdale MD, Polland AR, Graversen JA, Sartori S, Hruby GW, Landman J, McKiernan JM, Benson MC, Badani KK.

J Endourol. 2011 Sep;25(9):1427-33. doi: 10.1089/end.2010.0688. Epub 2011 Jul 28.

PMID:
21797762
19.

Statin use and prostate cancer risk in a large population-based setting.

Boudreau DM, Yu O, Buist DS, Miglioretti DL.

Cancer Causes Control. 2008 Sep;19(7):767-74. doi: 10.1007/s10552-008-9139-4. Epub 2008 Mar 6.

20.

Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.

Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA.

Ann Oncol. 2013 Jun;24(6):1427-34. doi: 10.1093/annonc/mdt077. Epub 2013 Mar 18. Review.

Supplemental Content

Support Center